Related Experiment Video
Updated: Jan 8, 2026

Studying the Hypothalamic Insulin Signal to Peripheral Glucose Intolerance with a Continuous Drug Infusion System into the Mouse Brain
Published on: January 4, 2018
DOCK10 Regulates Insulin Hypersecretion in Insulinoma and Serves as a Diagnostic and Therapeutic Target
Hiromune Katsuda1, Go Ito2, Franziska Kimmig3
1Department of Gastroenterology and Hepatology, Institute of Science Tokyo, Tokyo, Japan.
Background & Aims:
Insulinomas are rare pancreatic neuroendocrine neoplasms (pan-NENs) characterized by inappropriate insulin secretion. Despite advances in imaging techniques, the reliable identification of insulin-secreting lesions remains challenging. In addition, medical treatment options are limited and have seen little development in recent years, highlighting the unmet need for improved diagnostic tools and therapeutic strategies. This study aimed to identify the molecular mechanisms underlying insulin hypersecretion in insulinomas.
Methods:
We established a biobank of human insulinoma surgical specimens and matched organoids. Comprehensive transcriptomic analyses-including bulk RNA sequencing, single-cell RNA sequencing, quantitative polymerase chain reaction, and immunohistochemistry-were conducted to identify genes enriched in insulin-secreting components. Functional validation was performed using MIN6 cells, a xenograft mouse model, and long-term cultured human insulinoma organoids.
Results:
We identified dedicator of cytokinesis 10 (DOCK10) as a gene selectively overexpressed in insulin-secreting components of insulinomas. DOCK10 knockdown impaired glucose-stimulated insulin secretion in both mouse insulinoma cells and patient-derived organoids. Inhibition of the downstream effector Cdc42 with ML141 reduced insulin hypersecretion and improved survival in a MIN6 xenograft mouse model. These findings uncover a previously unrecognized role of the DOCK10-Cdc42 axis in regulating insulin secretion in insulinoma.
Conclusions:
This study suggests that DOCK10 may serve as a diagnostic marker for insulin-secreting lesions and a potential therapeutic target in insulinoma. It provides mechanistic insights that may inform future strategies for precision diagnostics and treatment of functional pancreatic neuroendocrine tumors.
Insights
Researchers identified dedicator of cytokinesis 10 (DOCK10) as a key regulator of insulin secretion in insulinomas. Targeting the DOCK10-Cdc42 pathway may offer new diagnostic and therapeutic strategies for these rare pancreatic tumors.
Area of Science:
- Endocrinology
- Oncology
- Molecular Biology
Background:
- Insulinomas, rare pancreatic neuroendocrine neoplasms (pan-NENs), cause inappropriate insulin secretion, posing diagnostic and therapeutic challenges.
- Current diagnostic tools and treatments for insulinomas are limited, indicating a critical need for novel approaches.
Purpose of the Study:
- To elucidate the molecular mechanisms driving insulin hypersecretion in insulinomas.
- To identify potential diagnostic markers and therapeutic targets for insulinoma.
Main Methods:
- Established a biobank of human insulinoma specimens and organoids.
- Conducted comprehensive transcriptomic analyses (bulk RNA-seq, scRNA-seq, qPCR, IHC).
- Performed functional validation using cell lines, xenograft models, and patient-derived organoids.
Main Results:
- Identified dedicator of cytokinesis 10 (DOCK10) as significantly overexpressed in insulin-secreting insulinoma components.
- DOCK10 knockdown reduced glucose-stimulated insulin secretion in mouse cells and human organoids.
- Inhibition of the DOCK10-Cdc42 pathway with ML141 decreased insulin hypersecretion and improved survival in a mouse model.
Conclusions:
- The DOCK10-Cdc42 axis plays a crucial role in regulating insulin secretion in insulinoma.
- DOCK10 shows potential as a diagnostic marker for insulin-secreting lesions.
- DOCK10 represents a promising therapeutic target for insulinoma treatment.
Related Concept Videos
Insulin: The Receptor and Signaling Pathways
PI3K/mTOR/AKT Signaling Pathway
Insulin Secretory Vesicles
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Hormones Regulating Blood Glucose
In addition to accelerating glucose uptake and utilization, insulin has...
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
Insulin and C-peptide are...

